Memorial Sloan Kettering computational pathology spinoff raises $100M
Paige, a New York-based computational pathology startup, raised $100 million in a series C funding round. The company develops clinical decision support algorithms for oncology.
Paige, a New York-based computational pathology startup, raised $100 million in a series C funding round. The company develops clinical decision support algorithms for oncology.
The company, whose technology won FDA Breakthrough Device designation earlier this year and which signed a deal with Philips earlier this month, plans to use the money to support FDA clearance and other efforts.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.